中国注册研究中稳定性胸痛患者冠脉CT血管成像后按CAD-RADS推荐管理方式与临床结局的关联
基于中国注册研究14 232例稳定性胸痛患者,回顾性分析CCTA后按CAD-RADS 2.0推荐管理的适当性与4年临床结局的关联;适当管理仅占CAD-RADS 1-2的26%和3级的20%,并与较低MACE风险(HR 0.34)及更审慎使用ICA相关。
要点
- CCTA后按CAD-RADS 2.0适当管理在CAD-RADS 1-2级与较低MACE风险相关(HR 0.34),3级未见显著关联(HR 0.86,P=0.42)。
- 适当管理在CAD-RADS 1-2级和3级均与ICA使用减少相关(RR分别为0.40和0.33)。
- 仅26%的CAD-RADS 1-2级和20%的3级患者接受了适当的CCTA后管理。
核心结论
- 回顾性二次分析显示,按CAD-RADS 2.0进行适当CCTA后疾病管理与较低MACE风险和更审慎的ICA使用相关。
研究设计与样本
- 回顾性二次分析,2016年1月至2018年1月前瞻性纳入中国注册研究的连续稳定性胸痛CCTA患者14 232例(平均年龄61岁±13,男性8852例),随访4年,采用倾向评分匹配调整混杂。
诊断标准与关键数值
- 按CAD-RADS 2.0分类,回顾性判定CCTA后管理适当性;适当管理组MACEs的HR为0.34(95%CI:0.22,0.51;P<.001),CAD-RADS 1-2的NNT为21;CAD-RADS 3的HR为0.86(95%CI:0.49,1.85;P=.42)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文为回顾性二次分析。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Coronary Artery Disease Reporting and Data System (CAD-RADS) was developed to standardize and optimize disease management in patients after coronary CT angiography (CCTA), but the impact of CAD-RADS management recommendations on clinical outcomes remains unclear. Purpose To retrospectively assess the association between the appropriateness of post-CCTA management according to CAD-RADS version 2.0 and clinical outcomes. Materials and Methods From January 2016 to January 2018, consecutive participants with stable chest pain referred for CCTA were prospectively included in a Chinese registry and followed for 4 years. Retrospectively, CAD-RADS 2.0 classification and the appropriateness of post-CCTA management were determined. Propensity score matching (PSM) was used to adjust for confounding variables. Hazard ratios (HRs) for a major adverse cardiovascular event (MACE), relative risks for invasive coronary angiography (ICA), and the corresponding number needed to treat were estimated. Results Of the 14 232 included participants (mean age, 61 years ± 13 [SD]; 8852 male), 2330, 2756, and 2614 were retrospectively categorized in CAD-RADS 1, 2, and 3, respectively. Only 26% of participants with CAD-RADS 1-2 disease and 20% with CAD-RADS 3 received appropriate post-CCTA management. After PSM, appropriate post-CCTA management was associated with lower risk of MACEs (HR, 0.34; 95% CI: 0.22, 0.51; P < .001), corresponding to a number needed to treat of 21 in CAD-RADS 1-2 but not CAD-RADS 3 (HR, 0.86; 95% CI: 0.49, 1.85; P = .42). Appropriate post-CCTA management was associated with decreased use of ICA in CAD-RADS 1-2 (relative risk, 0.40; 95% CI: 0.29, 0.55; P < .001) and 3 (relative risk, 0.33; 95% CI: 0.28, 0.39; P < .001), resulting in a number needed to treat of 14 and 2, respectively. Conclusion In this retrospective secondary analysis, appropriate disease management after CCTA according to CAD-RADS 2.0 was associated with lower risk of MACEs and more prudent use of ICA. ClinicalTrials.gov registration no. NCT04691037 © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Leipsic and Tzimas in this issue.
引用
- Zhou J, Li C, Zhang H, et al. Association between Coronary Artery Disease Reporting and Data System-recommended Post-Coronary CT Angiography Management and Clinical Outcomes in Patients with Stable Chest Pain from a Chinese Registry. Radiology. 2023. PMID: 37310243. doi:10.1148/radiol.222965
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。